At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
In Brief
A Phase 3 clinical trial evaluating Azithromycin, Prednisolone, and 2 other interventions for Asthma and Wheezing. Completed, enrolled 607 participants across 16 sites.
Detailed Summary
This protocol is comprised of two separate, but linked, clinical trials for treating preschool-aged children with recurrent severe episodes of wheezing. The first study (APRIL) will try to prevent wheezing illness from developing using azithromycin. If a wheezing illness does occur, the second trial (OCELOT) will try to decrease the severity of symptoms using oral corticosteroids.
Study Details
Timeline
Interventions
Suspension, 12 mg/kg once daily for 5 days, maximum dose 500mg/day
Syrup, 1 mg/kg/dose twice daily for 5 days, maximum dose 60mg/day
Suspension, 12 mg/kg once daily for 5 days, maximum dose 500mg/day
Syrup, 1 mg/kg/dose twice daily for 5 days, maximum dose 60mg/day